ABT - ABBOTT LABORATORIES
Close
114.785
-0.245 -0.213%
Share volume: 53,110
Last Updated: Fri 27 Dec 2024 08:30:00 PM CET
Surgical and Medical Instrument Manufacturing :
-0.06%
PREVIOUS CLOSE
CHG
CHG%
$115.03
-0.25
-0.21%
Fundamental analysis
54%
Profitability
67%
Dept financing
33%
Liquidity
19%
Performance
56%
Performance
5 Days
0.84%
1 Month
-3.09%
3 Months
2.53%
6 Months
10.15%
1 Year
4.99%
2 Year
6.17%
Key data
Stock price
$114.78
DAY RANGE
$114.53 - $115.96
52 WEEK RANGE
$101.77 - $121.64
52 WEEK CHANGE
$4.72
DIVIDEND
$0.55
EX-DIVIDEND DATE
07/15/2024
NEXT EARNINGS DATE
10/16/2024
Company detail
CEO: Robert B. Ford
Region: US
Website: abbott.com
Employees: 115,000
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing
Region: US
Website: abbott.com
Employees: 115,000
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing
Abbott Laboratories discovers, develops, manufactures, and sells health care products. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases.
Recent news